{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:00:15Z","timestamp":1773270015280,"version":"3.50.1"},"reference-count":59,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,11,28]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>The study developed a mouse model of bone disseminated myeloma disease as in humans. The study established therapeutic potential of OPG variants to revert myeloma bone damage in vivo.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017007310","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T01:35:11Z","timestamp":1511314511000},"page":"2375-2385","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":11,"title":["Mesenchymal stem cells expressing osteoprotegerin variants inhibit osteolysis in a murine model of multiple myeloma"],"prefix":"10.1182","volume":"1","author":[{"given":"Jerome T.","family":"Higgs","sequence":"first","affiliation":[{"name":"Department of Pathology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo Hyoung","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pathology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishnu C.","family":"Ramani","sequence":"additional","affiliation":[{"name":"Department of Pathology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diptiman","family":"Chanda","sequence":"additional","affiliation":[{"name":"Department of Pathology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cherlene Y.","family":"Hardy","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph D.","family":"Sanderson","sequence":"additional","affiliation":[{"name":"Department of Pathology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5219-8379","authenticated-orcid":false,"given":"Selvarangan","family":"Ponnazhagan","sequence":"additional","affiliation":[{"name":"Department of Pathology and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2017,11,21]]},"reference":[{"issue":"3","key":"2019111607201584400_B1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/leu.2008.336","article-title":"Pathogenesis of myeloma bone disease","volume":"23","author":"Roodman","year":"2009","journal-title":"Leukemia"},{"issue":"4","key":"2019111607201584400_B2","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1634\/stemcells.2005-0220","article-title":"A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma","volume":"24","author":"Gunn","year":"2006","journal-title":"Stem Cells"},{"issue":"6","key":"2019111607201584400_B3","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1158\/1078-0432.CCR-1053-03","article-title":"Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and autocrine up-regulation of MCP-1","volume":"10","author":"J\u00f6hrer","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2019111607201584400_B4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10585-007-9108-4","article-title":"Extravasation and homing mechanisms in multiple myeloma","volume":"25","author":"Vande Broek","year":"2008","journal-title":"Clin Exp Metastasis"},{"issue":"2","key":"2019111607201584400_B5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/10428190903503438","article-title":"Osteoblastogenesis and tumor growth in myeloma","volume":"51","author":"Yaccoby","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"2019111607201584400_B6","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1182\/blood-2002-04-1190","article-title":"Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells","volume":"100","author":"Standal","year":"2002","journal-title":"Blood"},{"issue":"18","key":"2019111607201584400_B7","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N Engl J Med"},{"issue":"11","key":"2019111607201584400_B8","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111607201584400_B9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/SPC.0b013e328349dc17","article-title":"Antitumor effects of bisphosphonates: from the laboratory to the clinic","volume":"5","author":"Berenson","year":"2011","journal-title":"Curr Opin Support Palliat Care"},{"issue":"2","key":"2019111607201584400_B10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jjco\/hys215","article-title":"Current therapeutic strategy for multiple myeloma","volume":"43","author":"Suzuki","year":"2013","journal-title":"Jpn J Clin Oncol"},{"issue":"10","key":"2019111607201584400_B11","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1038\/sj.leu.2404814","article-title":"A new xenograft model of myeloma bone disease demonstrating the efficacy of human mesenchymal stem cells expressing osteoprotegerin by lentiviral gene transfer","volume":"21","author":"Rabin","year":"2007","journal-title":"Leukemia"},{"issue":"2","key":"2019111607201584400_B12","first-page":"287","article-title":"Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma","volume":"63","author":"Vanderkerken","year":"2003","journal-title":"Cancer Res"},{"issue":"11","key":"2019111607201584400_B13","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/sj.leu.2401501","article-title":"TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells","volume":"13","author":"Gazitt","year":"1999","journal-title":"Leukemia"},{"issue":"10","key":"2019111607201584400_B14","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/sj.leu.2402251","article-title":"TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy","volume":"15","author":"Lincz","year":"2001","journal-title":"Leukemia"},{"issue":"3","key":"2019111607201584400_B15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood.V98.3.795","article-title":"TRAIL\/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications","volume":"98","author":"Mitsiades","year":"2001","journal-title":"Blood"},{"issue":"5","key":"2019111607201584400_B16","doi-asserted-by":"crossref","first-page":"e35830","DOI":"10.1371\/journal.pone.0035830","article-title":"Targeting tumour-initiating cells with TRAIL based combination therapy ensures complete and lasting eradication of multiple myeloma tumours in vivo","volume":"7","author":"Vitovski","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"2019111607201584400_B17","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1158\/1541-7786.MCR-14-0492","article-title":"Variants of osteoprotegerin lacking TRAIL binding for therapeutic bone remodeling in osteolytic malignancies","volume":"13","author":"Higgs","year":"2015","journal-title":"Mol Cancer Res"},{"issue":"Pt 11","key":"2019111607201584400_B18","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1242\/jcs.02932","article-title":"Mesenchymal stem cells reside in virtually all post-natal organs and tissues","volume":"119","author":"da Silva Meirelles","year":"2006","journal-title":"J Cell Sci"},{"issue":"10","key":"2019111607201584400_B19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/gt.2008.35","article-title":"Therapeutic potential of genetically modified mesenchymal stem cells","volume":"15","author":"Kumar","year":"2008","journal-title":"Gene Ther"},{"issue":"8","key":"2019111607201584400_B20","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCRESAHA.111.243147","article-title":"Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease","volume":"109","author":"Williams","year":"2011","journal-title":"Circ Res"},{"issue":"2","key":"2019111607201584400_B21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.yexcr.2003.12.030","article-title":"Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow","volume":"295","author":"Tropel","year":"2004","journal-title":"Exp Cell Res"},{"issue":"21","key":"2019111607201584400_B22","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/jnci\/djh299","article-title":"Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents","volume":"96","author":"Studeny","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2019111607201584400_B23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4048\/jbc.2012.15.3.273","article-title":"Stem cell implants for cancer therapy: TRAIL-expressing mesenchymal stem cells target cancer cells in situ","volume":"15","author":"Reagan","year":"2012","journal-title":"J Breast Cancer"},{"key":"2019111607201584400_B24","doi-asserted-by":"crossref","first-page":"e503","DOI":"10.1038\/cddis.2013.19","article-title":"Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects","volume":"4","author":"Yu","year":"2013","journal-title":"Cell Death Dis"},{"issue":"11","key":"2019111607201584400_B25","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/mt.2009.153","article-title":"Transplantation of mesenchymal stem cells overexpressing RANK-Fc or CXCR4 prevents bone loss in ovariectomized mice","volume":"17","author":"Cho","year":"2009","journal-title":"Mol Ther"},{"issue":"21","key":"2019111607201584400_B26","doi-asserted-by":"crossref","first-page":"8329","DOI":"10.1158\/0008-5472.CAN-10-2179","article-title":"Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL","volume":"70","author":"Yang","year":"2010","journal-title":"Cancer Res"},{"issue":"12","key":"2019111607201584400_B27","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.4049\/jimmunol.148.12.3902","article-title":"Adhesion of B lymphoid (MPC-11) cells to type I collagen is mediated by integral membrane proteoglycan, syndecan","volume":"148","author":"Sanderson","year":"1992","journal-title":"J Immunol"},{"issue":"2","key":"2019111607201584400_B28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jcb.22701","article-title":"Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton","volume":"111","author":"Chanda","year":"2010","journal-title":"J Cell Biochem"},{"issue":"5","key":"2019111607201584400_B29","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1158\/0008-5472.CAN-03-1786","article-title":"Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy: long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor","volume":"64","author":"Ponnazhagan","year":"2004","journal-title":"Cancer Res"},{"issue":"23","key":"2019111607201584400_B30","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.1158\/1078-0432.CCR-09-1938","article-title":"Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis","volume":"15","author":"Chanda","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2019111607201584400_B31","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/art.30309","article-title":"Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production","volume":"63","author":"Oshita","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"11","key":"2019111607201584400_B32","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1002\/cncr.20652","article-title":"Incidence of multiple myeloma in Olmsted County, Minnesota: trend over 6 decades","volume":"101","author":"Kyle","year":"2004","journal-title":"Cancer"},{"issue":"6","key":"2019111607201584400_B33","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1056\/NEJM199608083350603","article-title":"A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome","volume":"335","author":"Pierce","year":"1996","journal-title":"N Engl J Med"},{"issue":"9","key":"2019111607201584400_B34","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1200\/JCO.1996.14.9.2552","article-title":"Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial","volume":"14","author":"Conte","year":"1996","journal-title":"J Clin Oncol"},{"issue":"5","key":"2019111607201584400_B35","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1634\/theoncologist.2010-0225","article-title":"The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future","volume":"16","author":"Pozzi","year":"2011","journal-title":"Oncologist"},{"issue":"18","key":"2019111607201584400_B36","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1200\/JCO.2012.47.7901","article-title":"International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease","volume":"31","author":"Terpos","year":"2013","journal-title":"J Clin Oncol"},{"issue":"8","key":"2019111607201584400_B37","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1158\/1078-0432.CCR-07-1430","article-title":"Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw","volume":"14","author":"Raje","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2019111607201584400_B38","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol"},{"issue":"1","key":"2019111607201584400_B39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2019111607201584400_B40","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0714.2011.01091.x","article-title":"Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients","volume":"41","author":"Vescovi","year":"2012","journal-title":"J Oral Pathol Med"},{"issue":"18","key":"2019111607201584400_B41","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.2106\/JBJS.J.00455","article-title":"Metatarsal stress fractures in patients with multiple myeloma treated with long-term bisphosphonates: a report of six cases","volume":"93","author":"Waterman","year":"2011","journal-title":"J Bone Joint Surg Am"},{"issue":"8","key":"2019111607201584400_B42","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1074\/jbc.M110.183277","article-title":"Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activity","volume":"286","author":"Ramani","year":"2011","journal-title":"J Biol Chem"},{"issue":"38","key":"2019111607201584400_B43","doi-asserted-by":"crossref","first-page":"26085","DOI":"10.1074\/jbc.M109.018473","article-title":"Syndecan-1 is required for robust growth, vascularization, and metastasis of myeloma tumors in vivo","volume":"284","author":"Khotskaya","year":"2009","journal-title":"J Biol Chem"},{"issue":"13","key":"2019111607201584400_B44","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1182\/blood.V98.13.3527","article-title":"Myeloma cells induce imbalance in the osteoprotegerin\/osteoprotegerin ligand system in the human bone marrow environment","volume":"98","author":"Giuliani","year":"2001","journal-title":"Blood"},{"issue":"5","key":"2019111607201584400_B45","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.leu.2404621","article-title":"Bone marrow mesenchymal stem cells are abnormal in multiple myeloma","volume":"21","author":"Corre","year":"2007","journal-title":"Leukemia"},{"issue":"10","key":"2019111607201584400_B46","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1080\/10428190701593644","article-title":"Mesenchymal stem cell abnormalities in patients with multiple myeloma","volume":"48","author":"Garderet","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"2019111607201584400_B47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.exphem.2009.11.009","article-title":"Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease","volume":"38","author":"Todoerti","year":"2010","journal-title":"Exp Hematol"},{"issue":"17","key":"2019111607201584400_B48","first-page":"5438","article-title":"Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo","volume":"63","author":"Farrugia","year":"2003","journal-title":"Cancer Res"},{"issue":"4","key":"2019111607201584400_B49","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1210\/endo-119-4-1654","article-title":"Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption","volume":"119","author":"McSheehy","year":"1986","journal-title":"Endocrinology"},{"issue":"Suppl 3","key":"2019111607201584400_B50","doi-asserted-by":"crossref","first-page":"iii81","DOI":"10.1136\/ard.60.90003.iii81","article-title":"Osteoprotegerin","volume":"60","author":"Feige","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2019111607201584400_B51","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1182\/blood-2003-02-0380","article-title":"Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index","volume":"102","author":"Terpos","year":"2003","journal-title":"Blood"},{"issue":"6","key":"2019111607201584400_B52","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1182\/blood-2002-09-2684","article-title":"RANK ligand and osteoprotegerin in myeloma bone disease","volume":"101","author":"Sezer","year":"2003","journal-title":"Blood"},{"issue":"2","key":"2019111607201584400_B53","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1074\/jbc.M113.491589","article-title":"Decreased affinity of recombinant human tumor necrosis factor-related apoptosis-inducing ligand (rhTRAIL) D269H\/E195R to osteoprotegerin (OPG) overcomes TRAIL resistance mediated by the bone microenvironment","volume":"289","author":"Bosman","year":"2014","journal-title":"J Biol Chem"},{"issue":"5","key":"2019111607201584400_B54","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1084\/jem.20051921","article-title":"Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi\u2019s sarcoma","volume":"203","author":"Khakoo","year":"2006","journal-title":"J Exp Med"},{"issue":"9","key":"2019111607201584400_B55","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1634\/stemcells.2008-0084","article-title":"Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model","volume":"26","author":"Ren","year":"2008","journal-title":"Stem Cells"},{"issue":"2","key":"2019111607201584400_B56","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1200\/JCO.2000.18.2.307","article-title":"Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy","volume":"18","author":"Ko\u00e7","year":"2000","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111607201584400_B57","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ijc.23939","article-title":"Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells","volume":"124","author":"Molloy","year":"2009","journal-title":"Int J Cancer"},{"issue":"3","key":"2019111607201584400_B58","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.leu.2405090","article-title":"The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study","volume":"22","author":"Ning","year":"2008","journal-title":"Leukemia"},{"issue":"2","key":"2019111607201584400_B59","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/stem.787","article-title":"Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo","volume":"30","author":"Xu","year":"2012","journal-title":"Stem Cells"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/25\/2375\/879324\/advances007310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/25\/2375\/879324\/advances007310.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T10:26:57Z","timestamp":1751020017000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/1\/25\/2375\/15765\/Mesenchymal-stem-cells-expressing-osteoprotegerin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,21]]},"references-count":59,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2017,11,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017007310","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,21]]}}}